Ironwood Pharmaceuticals Inc (IRWD)
3.44
+0.10
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
3.42
-0.02
(-0.58%)
After-Hours: 20:00
Ironwood Pharmaceuticals Profit Margin (Quarterly): 3.98% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.98% |
| June 30, 2024 | -0.91% |
| March 31, 2024 | -5.56% |
| December 31, 2023 | -0.92% |
| September 30, 2023 | 13.47% |
| June 30, 2023 | -989.2% |
| March 31, 2023 | 43.93% |
| December 31, 2022 | 45.59% |
| September 30, 2022 | 46.32% |
| June 30, 2022 | 38.14% |
| March 31, 2022 | 39.78% |
| December 31, 2021 | 35.32% |
| September 30, 2021 | 53.83% |
| June 30, 2021 | |
| March 31, 2021 | 44.94% |
| December 31, 2020 | 37.03% |
| September 30, 2020 | 33.27% |
| June 30, 2020 | 28.18% |
| March 31, 2020 | 4.18% |
| December 31, 2019 | 37.89% |
| September 30, 2019 | 15.74% |
| June 30, 2019 | 12.02% |
| March 31, 2019 | -86.26% |
| December 31, 2018 | -11.85% |
| September 30, 2018 | -265.4% |
| Date | Value |
|---|---|
| June 30, 2018 | -60.88% |
| March 31, 2018 | -62.39% |
| December 31, 2017 | 12.83% |
| September 30, 2017 | -37.20% |
| June 30, 2017 | -67.96% |
| March 31, 2017 | -100.6% |
| December 31, 2016 | -15.44% |
| September 30, 2016 | -50.23% |
| June 30, 2016 | -39.93% |
| March 31, 2016 | -20.13% |
| December 31, 2015 | -26.33% |
| September 30, 2015 | -119.8% |
| June 30, 2015 | -173.1% |
| March 31, 2015 | -114.8% |
| December 31, 2014 | -98.88% |
| September 30, 2014 | -248.2% |
| June 30, 2014 | -882.4% |
| March 31, 2014 | -339.8% |
| December 31, 2013 | -1.03K% |
| September 30, 2013 | -1.25K% |
| June 30, 2013 | -674.2% |
| March 31, 2013 | -2.88K% |
| December 31, 2012 | -162.5% |
| September 30, 2012 | 49.41% |
| June 30, 2012 | -279.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-989.2%
Minimum
Jun 2023
53.83%
Maximum
Sep 2021
-25.83%
Average
35.32%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -0.56% |
| Return on Invested Capital | -0.73% |
| Operating Margin (Quarterly) | 28.01% |
| Return on Net Operating Assets | -2.18% |